News | November 21, 2024
Siegfried opens global R&D Center for Drug Substances in Switzerland
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
The inspection scope had included six separate Biologics manufacturing units comprising of four Drug Substance and two Drug Product manufacturing plants
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
He holds a Master’s in Management from the National University of Singapore
The inspection concluded with the issuance of a form 483 with five observations
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Subscribe To Our Newsletter & Stay Updated
